Red Flags Detected

  • Securities Litigation (worsened) — Securities class action has advanced from initial filing to amended complaint stage with lead plaintiff appointed and motion to dismiss briefing underway.
NASDAQ: NMRA Neumora Therapeutics, Inc. 10-K

Neumora reports KOASTAL-2/-3 enrollment complete, adds obesity program, cuts staff 13%

Filed March 30, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 3, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade NMRA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov View full financials on EDGAR ↗

Generated by AI · Jun 4, 2026 1:52 AM